Global Orthokeratology Market

Orthokeratology Comprehensive Study by Type (Myopia, Hyperopia, Astigmatism, Presbyopia), Application (Ambulatory services, Hospitals, Clinics) Players and Region - Global Market Outlook to 2030

Orthokeratology Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Orthokeratology (Ortho-k) is a process that uses specially designed contact lenses to temporarily reshape outline of the cornea to reduce myopia (nearsightedness). It is a non-surgical procedure, which offers advantage of reduced risk in comparison to refractive surgery. Ortho-k lenses are also termed as corneal reshaping contact lenses or overnight contact lenses to correct or control myopia.This growth is primarily driven by Growing Geriatric Population .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Diseases & Therapeutic Areas sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Euclid (United States), GP Specialists (United States), E&E Optics (United States), Procornea (Nederland) and Alpha Corporation (Japan), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In April 2022,Euclid Vision Corp., a global leader in advanced orthokeratology and proactive myopia management initiatives, is pleased to announce its acquisition of Visionary Optics, a specialty scleral contact lens design and distribution pioneer. The acquisition signifies Euclid’s recognition of the value of joining forces with Visionary Optics, the only company in the US that concentrates almost exclusively on scleral contact lenses. The union of these two companies increases each establishment’s ability to provide comprehensive specialty contact lens care to more patients globally.
In January 2022, Euclid Systems Corporation announced that its new cloud-based customer portal, MyEuclid, is now being released in its initial stages. The new portal is interactive, with the goal of helping ECPs drive practice efficiency and optimize Euclid’s orthokeratology designs.Orthokeratology is fragmented with presence with key players.

Regulatory Insights:
The Food and Drug Administration (FDA) has alerted practitioners about two unapproved contact lens uses. The federal agency alerted practitioners that only two "theatrical" tinted contact lenses have been evaluated by the FDA for safety and effectiveness, and no orthokeratology (ortho-K) lenses have been approved for overnight wear.

Influencing Trend:
Technology Advancement in the Manufacturing Process

Market Growth Drivers:
Growing Geriatric Population and Increased Prevalence of Myopia in Adult

Challenges:
Shortage of Trained Ophthalmologists

Restraints:
High Treatment Cost

Opportunities:
Untapped Emerging Market

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Orthokeratology Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Orthokeratology Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Orthokeratology players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Orthokeratology Study Sheds Light on
— The Orthokeratology Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Orthokeratology industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Orthokeratology industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Myopia
  • Hyperopia
  • Astigmatism
  • Presbyopia
By Application
  • Ambulatory services
  • Hospitals
  • Clinics
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Geriatric Population
      • 3.2.2. Increased Prevalence of Myopia in Adult
    • 3.3. Market Challenges
      • 3.3.1. Shortage of Trained Ophthalmologists
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in the Manufacturing Process
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Orthokeratology, by Type, Application and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Orthokeratology (Value)
      • 5.2.1. Global Orthokeratology by: Type (Value)
        • 5.2.1.1. Myopia
        • 5.2.1.2. Hyperopia
        • 5.2.1.3. Astigmatism
        • 5.2.1.4. Presbyopia
      • 5.2.2. Global Orthokeratology by: Application (Value)
        • 5.2.2.1. Ambulatory services
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Clinics
      • 5.2.3. Global Orthokeratology Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Orthokeratology (Price)
      • 5.3.1. Global Orthokeratology by: Type (Price)
  • 6. Orthokeratology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Euclid (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GP Specialists (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. E&E Optics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Procornea (Nederland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Alpha Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global Orthokeratology Sale, by Type, Application and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Orthokeratology (Value)
      • 7.2.1. Global Orthokeratology by: Type (Value)
        • 7.2.1.1. Myopia
        • 7.2.1.2. Hyperopia
        • 7.2.1.3. Astigmatism
        • 7.2.1.4. Presbyopia
      • 7.2.2. Global Orthokeratology by: Application (Value)
        • 7.2.2.1. Ambulatory services
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Clinics
      • 7.2.3. Global Orthokeratology Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Orthokeratology (Price)
      • 7.3.1. Global Orthokeratology by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Orthokeratology: by Type(USD Million)
  • Table 2. Orthokeratology Myopia , by Region USD Million (2018-2023)
  • Table 3. Orthokeratology Hyperopia , by Region USD Million (2018-2023)
  • Table 4. Orthokeratology Astigmatism , by Region USD Million (2018-2023)
  • Table 5. Orthokeratology Presbyopia , by Region USD Million (2018-2023)
  • Table 6. Orthokeratology: by Application(USD Million)
  • Table 7. Orthokeratology Ambulatory services , by Region USD Million (2018-2023)
  • Table 8. Orthokeratology Hospitals , by Region USD Million (2018-2023)
  • Table 9. Orthokeratology Clinics , by Region USD Million (2018-2023)
  • Table 10. South America Orthokeratology, by Country USD Million (2018-2023)
  • Table 11. South America Orthokeratology, by Type USD Million (2018-2023)
  • Table 12. South America Orthokeratology, by Application USD Million (2018-2023)
  • Table 13. Brazil Orthokeratology, by Type USD Million (2018-2023)
  • Table 14. Brazil Orthokeratology, by Application USD Million (2018-2023)
  • Table 15. Argentina Orthokeratology, by Type USD Million (2018-2023)
  • Table 16. Argentina Orthokeratology, by Application USD Million (2018-2023)
  • Table 17. Rest of South America Orthokeratology, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Orthokeratology, by Application USD Million (2018-2023)
  • Table 19. Asia Pacific Orthokeratology, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Orthokeratology, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Orthokeratology, by Application USD Million (2018-2023)
  • Table 22. China Orthokeratology, by Type USD Million (2018-2023)
  • Table 23. China Orthokeratology, by Application USD Million (2018-2023)
  • Table 24. Japan Orthokeratology, by Type USD Million (2018-2023)
  • Table 25. Japan Orthokeratology, by Application USD Million (2018-2023)
  • Table 26. India Orthokeratology, by Type USD Million (2018-2023)
  • Table 27. India Orthokeratology, by Application USD Million (2018-2023)
  • Table 28. South Korea Orthokeratology, by Type USD Million (2018-2023)
  • Table 29. South Korea Orthokeratology, by Application USD Million (2018-2023)
  • Table 30. Taiwan Orthokeratology, by Type USD Million (2018-2023)
  • Table 31. Taiwan Orthokeratology, by Application USD Million (2018-2023)
  • Table 32. Australia Orthokeratology, by Type USD Million (2018-2023)
  • Table 33. Australia Orthokeratology, by Application USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Orthokeratology, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Orthokeratology, by Application USD Million (2018-2023)
  • Table 36. Europe Orthokeratology, by Country USD Million (2018-2023)
  • Table 37. Europe Orthokeratology, by Type USD Million (2018-2023)
  • Table 38. Europe Orthokeratology, by Application USD Million (2018-2023)
  • Table 39. Germany Orthokeratology, by Type USD Million (2018-2023)
  • Table 40. Germany Orthokeratology, by Application USD Million (2018-2023)
  • Table 41. France Orthokeratology, by Type USD Million (2018-2023)
  • Table 42. France Orthokeratology, by Application USD Million (2018-2023)
  • Table 43. Italy Orthokeratology, by Type USD Million (2018-2023)
  • Table 44. Italy Orthokeratology, by Application USD Million (2018-2023)
  • Table 45. United Kingdom Orthokeratology, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Orthokeratology, by Application USD Million (2018-2023)
  • Table 47. Netherlands Orthokeratology, by Type USD Million (2018-2023)
  • Table 48. Netherlands Orthokeratology, by Application USD Million (2018-2023)
  • Table 49. Rest of Europe Orthokeratology, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Orthokeratology, by Application USD Million (2018-2023)
  • Table 51. MEA Orthokeratology, by Country USD Million (2018-2023)
  • Table 52. MEA Orthokeratology, by Type USD Million (2018-2023)
  • Table 53. MEA Orthokeratology, by Application USD Million (2018-2023)
  • Table 54. Middle East Orthokeratology, by Type USD Million (2018-2023)
  • Table 55. Middle East Orthokeratology, by Application USD Million (2018-2023)
  • Table 56. Africa Orthokeratology, by Type USD Million (2018-2023)
  • Table 57. Africa Orthokeratology, by Application USD Million (2018-2023)
  • Table 58. North America Orthokeratology, by Country USD Million (2018-2023)
  • Table 59. North America Orthokeratology, by Type USD Million (2018-2023)
  • Table 60. North America Orthokeratology, by Application USD Million (2018-2023)
  • Table 61. United States Orthokeratology, by Type USD Million (2018-2023)
  • Table 62. United States Orthokeratology, by Application USD Million (2018-2023)
  • Table 63. Canada Orthokeratology, by Type USD Million (2018-2023)
  • Table 64. Canada Orthokeratology, by Application USD Million (2018-2023)
  • Table 65. Mexico Orthokeratology, by Type USD Million (2018-2023)
  • Table 66. Mexico Orthokeratology, by Application USD Million (2018-2023)
  • Table 67. Orthokeratology: by Type(USD/Units)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Orthokeratology: by Type(USD Million)
  • Table 74. Orthokeratology Myopia , by Region USD Million (2025-2030)
  • Table 75. Orthokeratology Hyperopia , by Region USD Million (2025-2030)
  • Table 76. Orthokeratology Astigmatism , by Region USD Million (2025-2030)
  • Table 77. Orthokeratology Presbyopia , by Region USD Million (2025-2030)
  • Table 78. Orthokeratology: by Application(USD Million)
  • Table 79. Orthokeratology Ambulatory services , by Region USD Million (2025-2030)
  • Table 80. Orthokeratology Hospitals , by Region USD Million (2025-2030)
  • Table 81. Orthokeratology Clinics , by Region USD Million (2025-2030)
  • Table 82. South America Orthokeratology, by Country USD Million (2025-2030)
  • Table 83. South America Orthokeratology, by Type USD Million (2025-2030)
  • Table 84. South America Orthokeratology, by Application USD Million (2025-2030)
  • Table 85. Brazil Orthokeratology, by Type USD Million (2025-2030)
  • Table 86. Brazil Orthokeratology, by Application USD Million (2025-2030)
  • Table 87. Argentina Orthokeratology, by Type USD Million (2025-2030)
  • Table 88. Argentina Orthokeratology, by Application USD Million (2025-2030)
  • Table 89. Rest of South America Orthokeratology, by Type USD Million (2025-2030)
  • Table 90. Rest of South America Orthokeratology, by Application USD Million (2025-2030)
  • Table 91. Asia Pacific Orthokeratology, by Country USD Million (2025-2030)
  • Table 92. Asia Pacific Orthokeratology, by Type USD Million (2025-2030)
  • Table 93. Asia Pacific Orthokeratology, by Application USD Million (2025-2030)
  • Table 94. China Orthokeratology, by Type USD Million (2025-2030)
  • Table 95. China Orthokeratology, by Application USD Million (2025-2030)
  • Table 96. Japan Orthokeratology, by Type USD Million (2025-2030)
  • Table 97. Japan Orthokeratology, by Application USD Million (2025-2030)
  • Table 98. India Orthokeratology, by Type USD Million (2025-2030)
  • Table 99. India Orthokeratology, by Application USD Million (2025-2030)
  • Table 100. South Korea Orthokeratology, by Type USD Million (2025-2030)
  • Table 101. South Korea Orthokeratology, by Application USD Million (2025-2030)
  • Table 102. Taiwan Orthokeratology, by Type USD Million (2025-2030)
  • Table 103. Taiwan Orthokeratology, by Application USD Million (2025-2030)
  • Table 104. Australia Orthokeratology, by Type USD Million (2025-2030)
  • Table 105. Australia Orthokeratology, by Application USD Million (2025-2030)
  • Table 106. Rest of Asia-Pacific Orthokeratology, by Type USD Million (2025-2030)
  • Table 107. Rest of Asia-Pacific Orthokeratology, by Application USD Million (2025-2030)
  • Table 108. Europe Orthokeratology, by Country USD Million (2025-2030)
  • Table 109. Europe Orthokeratology, by Type USD Million (2025-2030)
  • Table 110. Europe Orthokeratology, by Application USD Million (2025-2030)
  • Table 111. Germany Orthokeratology, by Type USD Million (2025-2030)
  • Table 112. Germany Orthokeratology, by Application USD Million (2025-2030)
  • Table 113. France Orthokeratology, by Type USD Million (2025-2030)
  • Table 114. France Orthokeratology, by Application USD Million (2025-2030)
  • Table 115. Italy Orthokeratology, by Type USD Million (2025-2030)
  • Table 116. Italy Orthokeratology, by Application USD Million (2025-2030)
  • Table 117. United Kingdom Orthokeratology, by Type USD Million (2025-2030)
  • Table 118. United Kingdom Orthokeratology, by Application USD Million (2025-2030)
  • Table 119. Netherlands Orthokeratology, by Type USD Million (2025-2030)
  • Table 120. Netherlands Orthokeratology, by Application USD Million (2025-2030)
  • Table 121. Rest of Europe Orthokeratology, by Type USD Million (2025-2030)
  • Table 122. Rest of Europe Orthokeratology, by Application USD Million (2025-2030)
  • Table 123. MEA Orthokeratology, by Country USD Million (2025-2030)
  • Table 124. MEA Orthokeratology, by Type USD Million (2025-2030)
  • Table 125. MEA Orthokeratology, by Application USD Million (2025-2030)
  • Table 126. Middle East Orthokeratology, by Type USD Million (2025-2030)
  • Table 127. Middle East Orthokeratology, by Application USD Million (2025-2030)
  • Table 128. Africa Orthokeratology, by Type USD Million (2025-2030)
  • Table 129. Africa Orthokeratology, by Application USD Million (2025-2030)
  • Table 130. North America Orthokeratology, by Country USD Million (2025-2030)
  • Table 131. North America Orthokeratology, by Type USD Million (2025-2030)
  • Table 132. North America Orthokeratology, by Application USD Million (2025-2030)
  • Table 133. United States Orthokeratology, by Type USD Million (2025-2030)
  • Table 134. United States Orthokeratology, by Application USD Million (2025-2030)
  • Table 135. Canada Orthokeratology, by Type USD Million (2025-2030)
  • Table 136. Canada Orthokeratology, by Application USD Million (2025-2030)
  • Table 137. Mexico Orthokeratology, by Type USD Million (2025-2030)
  • Table 138. Mexico Orthokeratology, by Application USD Million (2025-2030)
  • Table 139. Orthokeratology: by Type(USD/Units)
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Orthokeratology: by Type USD Million (2018-2023)
  • Figure 5. Global Orthokeratology: by Application USD Million (2018-2023)
  • Figure 6. South America Orthokeratology Share (%), by Country
  • Figure 7. Asia Pacific Orthokeratology Share (%), by Country
  • Figure 8. Europe Orthokeratology Share (%), by Country
  • Figure 9. MEA Orthokeratology Share (%), by Country
  • Figure 10. North America Orthokeratology Share (%), by Country
  • Figure 11. Global Orthokeratology: by Type USD/Units (2018-2023)
  • Figure 12. Global Orthokeratology share by Players 2023 (%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Euclid (United States) Revenue, Net Income and Gross profit
  • Figure 15. Euclid (United States) Revenue: by Geography 2023
  • Figure 16. GP Specialists (United States) Revenue, Net Income and Gross profit
  • Figure 17. GP Specialists (United States) Revenue: by Geography 2023
  • Figure 18. E&E Optics (United States) Revenue, Net Income and Gross profit
  • Figure 19. E&E Optics (United States) Revenue: by Geography 2023
  • Figure 20. Procornea (Nederland) Revenue, Net Income and Gross profit
  • Figure 21. Procornea (Nederland) Revenue: by Geography 2023
  • Figure 22. Alpha Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Alpha Corporation (Japan) Revenue: by Geography 2023
  • Figure 24. Global Orthokeratology: by Type USD Million (2025-2030)
  • Figure 25. Global Orthokeratology: by Application USD Million (2025-2030)
  • Figure 26. South America Orthokeratology Share (%), by Country
  • Figure 27. Asia Pacific Orthokeratology Share (%), by Country
  • Figure 28. Europe Orthokeratology Share (%), by Country
  • Figure 29. MEA Orthokeratology Share (%), by Country
  • Figure 30. North America Orthokeratology Share (%), by Country
  • Figure 31. Global Orthokeratology: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Euclid (United States)
  • GP Specialists (United States)
  • E&E Optics (United States)
  • Procornea (Nederland)
  • Alpha Corporation (Japan)
Additional players considered in the study are as follows:
Lucid (Korea) , TMVC (Taiwan) , Autek China (China)
Select User Access Type

Key Highlights of Report


Jan 2024 214 Pages 63 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Orthokeratology Market Quantitative research analysis
Global Orthokeratology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Orthokeratology Market are Euclid (United States), GP Specialists (United States), E&E Optics (United States), Procornea (Nederland) and Alpha Corporation (Japan) etc.
Ambulatory services segment in Global market to hold robust market share owing to "Growing Geriatric Population ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Orthokeratology market throughout the forecasted period.

Know More About Global Orthokeratology Market Report?

Have a Query? Click Here

Other Related Reports

Orthopedic Prosthetics Comprehensive Study by Type (Upper Extremity Prosthetics (Hand Prosthetics, Elbow Prosthetics, Shoulder Prosthetics), Lower Extremity Prosthetics (Foot & Ankle Prosthetics, Kne...
$ 3750
Substance Abuse Treatment Comprehensive Study by Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Drug Abuse Treatment, Other Treatment), Distribution Channel (Hospital Pharma...
$ 3650
Hemophilia Treatment Comprehensive Study by Type (Replacement therapy, ITI therapy, Gene therapy), Disease Type (Hemophilia A, Hemophilia B, Hemophilia C), Treatment (Recombinant Coagulation Factor, ...
$ 3650
Gastrointestinal Cancer Drugs Comprehensive Study by Application (Hospitals, Specialized Cancer Treatment Centers, Clinics, Ambulatory Surgical Centers), Drug Type (Ramucirumab, Docetaxel, Doxorubici...
$ 3750
Hormone Refractory Prostate Cancer Comprehensive Study by Treatment (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiation Therapy, Surgery), End-users (Hospitals, Ambulatory Surgical Centers, Spe...
$ 3650
Metastatic Uveal Melanoma Thereapeutics Comprehensive Study by Type (Sunitinib Malate, Vincristine Sulfate Liposomal, LY-2801653, Sotrastaurin Acetate, Others), Application (Hospital, Clinic, Others)...
$ 3750